Robotic Surgery for Rectal Cancer: General Surgery News Report
(MedPage Today) -- Also, how well does a risk calculator predict emergency surgery outcomes? (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - October 3, 2018 Category: American Health Source Type: news
Neoadjuvant Score as Surrogate for DFS in Rectal Cancer Neoadjuvant Score as Surrogate for DFS in Rectal Cancer
A score incorporating categories for disease-free survival can help clinicians make faster decisions about treatment for rectal cancer.Annals of Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 16, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
Does Guideline-Driven Care Confer Benefit in Younger Rectal Cancer Patients?
The survival advantages associated with NCCN guideline –driven care were not realized in younger patients with stage II and stage III rectal cancer. (Source: CancerNetwork)
Source: CancerNetwork - August 9, 2018 Category: Cancer & Oncology Authors: Leah Lawrence Source Type: news
MRI finds key indicators of rectal cancer prognosis
Two key characteristics on MRI scans of rectal cancer patients can help predict...Read more on AuntMinnie.comRelated Reading:
Lancet: Cancer survival rates improve but vary widely
ASTRO releases updated rectal cancer treatment guide
Radiation plus surgery boosts rectal cancer survival
PET/CT predicts response to endorectal radiotherapy
SNM: PET/CT predicts colorectal cancer outcomes (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 31, 2018 Category: Radiology Source Type: news
Arizona Team IDs Attributes of Younger Rectal Cancer Patients
The most common presentation among the younger patients was bleeding, and they were more likely have a family history of rectal cancer. (Source: CancerNetwork)
Source: CancerNetwork - July 24, 2018 Category: Cancer & Oncology Authors: John Schieszer Source Type: news
Should Clinicians Rethink Rectal Cancer Treatment for Younger Patients?
Early ‐onset rectal cancer may differ biologically and in its response to multimodality therapy, according to a large retrospective study of NCCN data. (Source: CancerNetwork)
Source: CancerNetwork - July 18, 2018 Category: Cancer & Oncology Authors: John Schieszer Source Type: news
Rx Guidelines Do Not Benefit Younger Rectal Cancer Patients Rx Guidelines Do Not Benefit Younger Rectal Cancer Patients
Younger patients with rectal cancer do not derive an overall survival benefit from guideline-driven treatment recommendations, whereas older rectal cancer patients do.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 11, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Living With Cancer: Diagnosing and treating rectal cancer
Rectal cancer: Diagnosis and treatment? In the past, long-term survival was uncommon for people with rectal cancer ? even after extensive treatment. Thanks to treatment advances over the past 30 years, rectal cancer can be cured in many cases. Learn about the diagnosis and staging of rectal cancer, and the treatment options that might be [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - July 11, 2018 Category: Databases & Libraries Source Type: news
Guideline Care Fails to Boost Survival in Younger Rectal Cancer Patients
(MedPage Today) -- Those younger than 50 with Stages II-III disease may represent ' unique demographic group ' (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - July 9, 2018 Category: Gastroenterology Source Type: news
Current rectal cancer treatments don't benefit patients under 50, study says
Rectal cancer patients under 50 don't see an improvement to their overall survival after receiving recommended treatments, researchers found in a study. (Source: Health News - UPI.com)
Source: Health News - UPI.com - July 9, 2018 Category: Consumer Health News Source Type: news
Younger patients don't attain survival benefit from current rectal cancer treatment recommendations
(Wiley) A new study reveals that individuals younger than 50 years of age who are diagnosed with rectal cancer do not experience an overall survival benefit from currently recommended treatments. Specifically, the addition of chemotherapy and radiation to surgery does not prolong life for these patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 9, 2018 Category: International Medicine & Public Health Source Type: news
OCUM Trial: Some Rectal Cancers Need Only Surgery OCUM Trial: Some Rectal Cancers Need Only Surgery
The German study used MRI to help distinguish between high- and low-risk rectal cancers, which, in turn, dictated treatmentMedscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 26, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Adjuvant FOLFOX Improved DFS in yp Stage III Rectal Cancer
Leah LawrenceJun 6, 2018In the ADORE trial, adjuvant FOLFOX in postoperative yp stage III rectal cancer significantly improved disease-free survival. (Source: CancerNetwork)
Source: CancerNetwork - June 6, 2018 Category: Cancer & Oncology Authors: A Source Type: news
Young Rectal Cancer Patients Are Typically Women, White Young Rectal Cancer Patients Are Typically Women, White
Researchers are baffled by the annual increases in rates of rectal cancer seen in people younger than 50 years.Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 6, 2018 Category: Consumer Health News Tags: Gastroenterology News Source Type: news
American Cancer Society Advises Colon Screenings Should Begin at 45, Not 50
NEW YORK (AP) — New guidelines released Wednesday recommend U.S. adults start colon cancer screening earlier, at age 45 instead of 50.
The American Cancer Society's advice puts it out of sync with guidelines from an influential government advisory group, which kept the age at 50 in an update two years ago.
Cancer society officials acknowledge the shift to 45 could cause confusion for doctors and patients but felt strongly that they needed to act now. The advocacy group was influenced by its study, published last year, that found rising rates of colon cancer and deaths in people younger than 50. Experts aren't sure why th...
Source: JEMS Patient Care - May 31, 2018 Category: Emergency Medicine Authors: Mike Stobbe, Associated Press Tags: Patient Care News Source Type: news
